Financials in USD. Standardized financial statements.
A compact view of how Moolec Science S.A. turns revenue into operating income and net income.
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Revenue? | $333.61M | $5.63M | $905,049 | $0 | $0 |
| Revenue Growth? | +5830.7% | +521.5% | 0.0% | 0.0% | 0.0% |
| Cost of Revenue? | $219.61M | $5.15M | $1.05M | $0 | $0 |
| Gross Profit? | $114.01M | $472,581 | -$143,305 | $0 | $0 |
| Gross Margin? | +34.2% | +8.4% | -15.8% | 0.0% | 0.0% |
| Operating Expenses? | $124.48M | $9.52M | $6.51M | $3.65M | $13,802 |
| Operating Income? | -$10.48M | -$9.04M | -$6.65M | -$1.72M | -$13,800 |
| EBITDA? | -$69.01M | -$6.16M | -$51.74M | -$3.65M | -$13,800 |
| Income Before Tax | -$170.00M | -$8.34M | -$52.02M | -$93,808 | -$13,802 |
| Income Tax Expense | $6.64M | -$1.05M | -$234,542 | $0 | $0 |
| Net Income? | -$111.46M | -$7.31M | -$51.79M | -$4.53M | -$13,802 |
| EPS? | $-258.75 | $-2.85 | $-22.50 | $-1.80 | $-0.01 |
| Diluted EPS? | $-258.75 | $-2.85 | $-22.50 | $-1.80 | $-0.01 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality